Literature DB >> 11591625

Effect of short pulsed nonablative infrared laser irradiation on vascular cells in vitro and neointimal hyperplasia in a rabbit balloon injury model.

N Kipshidze1, V Nikolaychik, M Muckerheidi, M H Keelan, V Chekanov, M Maternowski, P Chawla, I Hernandez, S Iyer, G Dangas, H Sahota, M B Leon, G Roubin, J W Moses.   

Abstract

BACKGROUND: Neointimal hyperplasia after PTCA is an important component of restenosis. METHODS AND
RESULTS: Cultures of rabbit endothelial cells and smooth muscle cells (SMCs) were irradiated with different doses of nonablative infrared (1064-nm) radiation. Normalized viability index detected with nondestructive Alamar Blue assay and direct cell count were studied. Our experiments demonstrated dose-dependent cytostatic or cytotoxic effects of laser irradiation. We also evaluated the long-term effect of endoluminal nonablative infrared laser irradiation on neointimal hyperplasia in a rabbit balloon injury model. PTCA of both iliac arteries of 23 New Zealand White rabbits was performed. One iliac artery was subjected to intra-arterial subablative infrared irradiation via a diffuse tip fiber. The contralateral vessel served as control. The diet was supplemented with 0.25% cholesterol and 2% peanut oil for 10 days before and 60 days after PTCA. Morphometry after 60 days showed that intimal areas were 0.76+/-0.18 and 1.85+/-0.30 mm(2) in the laser and control arteries, respectively (P=2.2x10(-11)).
CONCLUSIONS: We conclude that nonablative infrared laser inhibited neointimal hyperplasia after PTCA in cholesterol-fed rabbits for up to 60 days.

Entities:  

Mesh:

Year:  2001        PMID: 11591625     DOI: 10.1161/hc3901.096101

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

Review 1.  Far-infrared therapy for cardiovascular, autoimmune, and other chronic health problems: A systematic review.

Authors:  Shanshan Shui; Xia Wang; John Y Chiang; Lei Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-25

2.  Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1.

Authors:  Chih-Ching Lin; Xiao-Ming Liu; Kelly Peyton; Hong Wang; Wu-Chang Yang; Shing-Jong Lin; William Durante
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-17       Impact factor: 8.311

Review 3.  Novel therapies for hemodialysis vascular access dysfunction: myth or reality?

Authors:  Christi M Terry; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

Review 4.  Role of far infra-red therapy in dialysis arterio-venous fistula maturation and survival: systematic review and meta-analysis.

Authors:  Khalid Bashar; Donagh Healy; Leonard D Browne; Elrasheid A H Kheirelseid; Michael T Walsh; Mary Clarke-Moloney; Paul E Burke; Eamon G Kavanagh; Stewart Redmond Walsh
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

5.  Effects of far infrared therapy on arteriovenous fistulas in hemodialysis patients: a meta-analysis.

Authors:  Qingsong Wan; Shikun Yang; Li Li; Fenfen Chu
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

6.  Germanium-Titanium-π Polymer Composites as Functional Textiles for Clinical Strategy to Evaluate Blood Circulation Improvement and Sexual Satisfaction.

Authors:  Yu-Cing Juho; Shou-Hung Tang; Yi-Hsin Lin; Chen-Xi Lin; Tenson Liang; Juin-Hong Cherng; En Meng
Journal:  Polymers (Basel)       Date:  2021-11-27       Impact factor: 4.329

7.  Far-Infrared Therapy Improves Arteriovenous Fistula Patency and Decreases Plasma Asymmetric Dimethylarginine in Patients with Advanced Diabetic Kidney Disease: A Prospective Randomized Controlled Trial.

Authors:  Chun-Fan Chen; Chiu-Yang Lee; Fu-An Chen; Chih-Yu Yang; Tz-Heng Chen; Shuo-Ming Ou; Kuo-Hua Lee; Ching-Po Li; Chia-Hao Chan; Pui-Ching Lee; Yung-Tai Chen; Tsung-Lun Lee; Yang Ho; Fan-Yu Chen; Hao-Wei Ma; Jinn-Yang Chen; Ann Charis Tan; Szu-Yuan Li; Chih-Ching Lin
Journal:  J Clin Med       Date:  2022-07-18       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.